Answer
Nov 14, 2024 - 01:39 PM
Neuroleptic malignant syndrome is a potentially life-threatening condition that can occur with Abilify, especially when combined with other dopaminergic agents. Recognizing this risk is critical for prompt intervention and management in case symptoms arise.
